FRAX Score: Fracture Risk Assessment and Osteoporosis Management

FRAX calculates 10-year probability of major osteoporotic fracture (MOF) and hip fracture using 12 clinical risk factors with or without bone mineral density. A FRAX-based treat threshold of ≥20% MOF or ≥3% hip fracture is widely used in the US. FRAXplus (2024) addresses several limitations.

TL;DR: FRAX calculates 10-year probability of major osteoporotic fracture and hip fracture using 12 clinical risk factors with or without BMD. Treat threshold: ≥20% MOF or ≥3% hip fracture (US). FRAXplus (2024) addresses several limitations.


FRAX Input Variables

Age, sex, weight, height, prior fragility fracture, parental hip fracture, current smoking, glucocorticoids, rheumatoid arthritis, secondary osteoporosis, alcohol ≥3 units/day, femoral neck BMD T-score (optional).


Treatment Thresholds

OutcomeThreshold
Major osteoporotic fracture≥20% → Treat
Hip fracture≥3% → Treat

Evidence

Schini M et al. (2024) reviewed FRAX across 15 years — incorporated into 80+ national guidelines covering 79% of the world population.

Kanis JA et al. (2017) documented 63 country models and treatment efficacy correlation with baseline FRAX probability.


References

  1. Schini M, et al. J Endocrinol Invest. 2024;47(3):501–511. PMID: 37874461.
  2. Kanis JA, et al. J Clin Densitom. 2017;20(3):360–367. PMID: 28732576.
  3. McCloskey EV, et al. Curr Opin Rheumatol. 2016;28(4):433–441. PMID: 27163858.